1. Home
  2. TEI vs TOI Comparison

TEI vs TOI Comparison

Compare TEI & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TEI

Templeton Emerging Markets Income Fund Inc.

HOLD

Current Price

$6.26

Market Cap

324.9M

Sector

Finance

ML Signal

HOLD

Logo The Oncology Institute Inc.

TOI

The Oncology Institute Inc.

HOLD

Current Price

$3.97

Market Cap

304.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TEI
TOI
Founded
1993
2007
Country
United States
United States
Employees
N/A
641
Industry
Finance Companies
Medical/Nursing Services
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
324.9M
304.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TEI
TOI
Price
$6.26
$3.97
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$6.67
AVG Volume (30 Days)
134.0K
1.5M
Earning Date
01-01-0001
05-07-2026
Dividend Yield
10.51%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$30.15
Revenue Next Year
N/A
$25.77
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.44
$2.02
52 Week High
$7.00
$4.88

Technical Indicators

Market Signals
Indicator
TEI
TOI
Relative Strength Index (RSI) 41.19 58.84
Support Level $6.19 $3.35
Resistance Level $6.48 $4.15
Average True Range (ATR) 0.14 0.25
MACD -0.02 0.00
Stochastic Oscillator 23.61 66.16

Price Performance

Historical Comparison
TEI
TOI

About TEI Templeton Emerging Markets Income Fund Inc.

Templeton Emerging Markets Income Fund is a closed-end fund. It seeks high, current income, with a secondary goal of capital appreciation, by investing, under normal market conditions. The company's investment portfolio includes Foreign Government and Agency Securities; Quasi-Sovereign and Corporate Bonds; Common Stocks and Other Equity Interests, and Short-Term Investments, and Money Market Funds.

About TOI The Oncology Institute Inc.

The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.

Share on Social Networks: